4.35
4.35 (0%)
As of Feb 14, 2025
Briacell Therapeutics Corp. [BCTX]
Source:
Company Overview
Briacell Therapeutics Corp. is a clinical-stage biotechnology company that is developingnovel immunotherapies to transform cancer care.
| Country | United States |
| Headquarters | west vancouver |
| Phone Number | (604) 921-1810 |
| Industry | manufacturing |
| CEO | William V. Williams |
| Website | briacell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-7.2 |
| Net Income | $-6.3 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -83.2% |
| Profit as % of Stockholder Equity | -196.4% |
Management Effectiveness
| Return on Equity | -196.4% |
| Return on Assets | -67.7% |
| Turnover Ratio | |
| EBITA | $-7.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $9.4 |
| Total Liabilities | $6.1 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
